• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing
  3. / Healthcare

Your Advantage Over Buffett

He can't buy into these small-cap wonders.
By JOHN REESE
Feb 23, 2015 | 07:00 AM EST
Stocks quotes in this article: BRK.A, FCFS, HIBB, CRVL

It's tough keeping up with Warren Buffett.

He has tens of billions of dollars at his disposal via the balance sheet of his company, Berkshire Hathaway (BRK.A), access to analysts in his employ and, of course, the ability to contact CEOs and others in the know and have them answer his phone call. Let's be honest: He has inherent advantages over the average Joe. 

But in one important way, folks like you and me have an advantage over him. Because Buffett has so much money to invest, he typically cannot buy into small-cap companies. Berkshire Hathaway has a market cap of about $360 billion that includes an investment portfolio worth north of $100 billion, which means investing in companies with market caps of a billion or two is uneconomical. Buying 10% of a $1 billion company would hardly register on Berkshire Hathaway's balance sheet. For this reason, though Berkshire will sometimes play in the small-cap space, it primarily sticks to larger-cap opportunities. 

But unless you suffer from Buffett's affliction of having billions to invest, you can invest in small-caps and do so using essentially his strategy. Years ago, I automated the strategies employed by the best investors, including Buffett. I based my Buffett-inspired strategy on the Buffett-oriented approach Mary Buffett (his former daughter-in-law) described in her book, Buffettology. Right now, three smaller-cap stocks earn this strategy's highest rating. You can now travel where Buffett might want to go, if only he were you. 

First Cash Financial Services (FCFS), with a market cap of $1.4 billion, operates over 800 pawn and consumer finance stores in the U.S. and Mexico. This company is a major player in its market that has managed to improve its EPS every year over the past decade. Its average return on equity is a hefty $18.1% during the past 10 years, while its average return on assets in the same time period was a strong 13.4%. My Buffett-based strategy projects how much an investor can expect to earn on the stock in the next 10 years based on buying at today's price. In the case of First Cash, the strategy projects a 16% annual return. Can't complain about that. 

In our country's small- to mid-sized markets, one can often find a Hibbett Sports store. Calling itself "a neighborhood sporting goods store," the company (HIBB), which has a market cap of $1.2 billion, operates over 960 stores in 31 states. The company is very strong in the markets where it operates, has enjoyed increased EPS in eight of the past 10 years, has no long-term debt and an average return on equity of 23.7% over the trailing decade. In addition, the strategy projects an annual return to investors of 18.3%. A solid performer within its market niche. 

CorVel (CRVL) is a medical claims management company with a $723 million market cap. The company seeks to improve health care management for employers, third-party administrators, insurance companies and government agencies. The company has no debt, EPS that has increased in eight of the past 10 years, return on equity of 21.6% and return on total capital that is also 21.6%. Expect to earn 16.3% on your investment, according to this strategy. As with First Cash and Hibbett, CorVel is a solid company with a well-priced stock.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Reese was long FCFS and HIBB, although positions may change at any time.

TAGS: Investing | U.S. Equity | Healthcare

More from Healthcare

Checking In on Pacific Biosciences to See If It's Still a Good 'Idea'

Bruce Kamich
Mar 31, 2023 9:02 AM EDT

Let's review the charts of PACB again.

Does Silk Road Medical Have a Smooth Path Forward?

Bruce Kamich
Mar 31, 2023 8:11 AM EDT

After gaining a fundamental supporter, here's how aggressive traders could play the stock.

Medtronic Could Touch a New Low as It Bottoms

Bruce Kamich
Mar 29, 2023 9:30 AM EDT

Let's see what the the charts and indicators look like.

Gilead Sciences Could Retreat Further From Here

Bruce Kamich
Mar 27, 2023 9:25 AM EDT

Share prices peaked in December.

Boston Scientific's Wicked Rally Can Take the Stock 20% Higher

Bruce Kamich
Mar 21, 2023 2:59 PM EDT

BSX has rallied the past nine months.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 08:21 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    How a Trader Becomes a Money Manager
  • 04:00 PM EDT CHRIS VERSACE

    AAP Podcast: This Solar Company Is a Head-Turner

    Listen to my interview with Brian Roth, CEO of sol...
  • 01:56 PM EDT PETER TCHIR

    Very Cautious

    I am very cautious here. I don't like how the c...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login